Institutional Ownership Corcept Therapeutics Inc (CORT)
This table provides information about the institutional ownership of Corcept Therapeutics Inc (CORT). We have compiled data on the 463 institutions that hold shares in the stock, with a total of 82.7 Million shares, which have been reported (via 13F filing form) to have a value of $6.09 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,539,159
shares
|
$1.22 Billion
0.01% of portfolio
|
Q2 2024
Reduced 1.71%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
9,680,592
shares
|
$712 Million
0.01% of portfolio
|
Q2 2025
Reduced 3.02%
|
|
|
Ingalls & Snyder LLC
New York, NY |
Jul 31, 2025 Q2 2025 |
7,722,922
shares
|
$568 Million
20.11% of portfolio
|
Q2 2025
Reduced 0.25%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
6,266,402
shares
|
$461 Million
0.65% of portfolio
|
Q2 2025
Added 2.01%
|
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
3,871,123
shares
|
$285 Million
5.83% of portfolio
|
Q2 2025
Reduced 2.55%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,967,587
shares
|
$218 Million
0.01% of portfolio
|
Q2 2025
Reduced 12.77%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,085,517
shares
|
$153 Million
0.04% of portfolio
|
Q2 2025
Reduced 2.39%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,915,616
shares
|
$141 Million
0.01% of portfolio
|
Q2 2025
Reduced 15.24%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,614,093
shares
|
$119 Million
0.01% of portfolio
|
Q2 2025
Added 4.91%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
1,167,935
shares
|
$85.9 Million
0.07% of portfolio
|
Q2 2025
Added 330.74%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
1,031,741
shares
|
$75.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 17.21%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
981,577
shares
|
$72.2 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
819,882
shares
|
$60.3 Million
0.06% of portfolio
|
Q2 2025
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
814,455
shares
|
$59.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 21.06%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
788,809
shares
|
$58 Million
0.04% of portfolio
|
Q2 2025
Reduced 47.14%
|
|
|
Epoch Investment Partners, Inc.
New York, NY |
Aug 13, 2025 Q2 2025 |
765,404
shares
|
$56.3 Million
0.31% of portfolio
|
Q2 2025
New holding
|
|
|
Cerity Partners LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
746,593
shares
|
$54.9 Million
0.1% of portfolio
|
Q2 2025
Added 21.44%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
673,137
shares
|
$49.5 Million
0.04% of portfolio
|
Q2 2025
Reduced 3.87%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
652,303
shares
|
$48 Million
0.01% of portfolio
|
Q2 2025
Reduced 36.17%
|
|
|
Jupiter Asset Management LTD
|
Aug 08, 2025 Q2 2025 |
601,394
shares
|
$44.3 Million
0.4% of portfolio
|
Q2 2025
Reduced 0.42%
|
|
|
Boston Trust Walden Corp
|
Jul 28, 2025 Q2 2025 |
572,072
shares
|
$42.1 Million
0.3% of portfolio
|
Q2 2025
Reduced 2.18%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
566,269
shares
|
$41.7 Million
0.03% of portfolio
|
Q2 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
560,669
shares
|
$41.3 Million
0.01% of portfolio
|
Q2 2025
Added 10.95%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Aug 13, 2025 Q2 2025 |
537,186
shares
|
$39.5 Million
0.03% of portfolio
|
Q2 2025
Reduced 41.88%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
535,449
shares
|
$39.4 Million
0.02% of portfolio
|
Q2 2025
Added 0.94%
|